Envoy Medical, Inc.
COCH
$0.84
$0.045.07%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 208.00K | 222.00K | 212.00K | 225.00K | 278.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 208.00K | 222.00K | 212.00K | 225.00K | 278.00K |
| Cost of Revenue | 820.00K | 804.00K | 815.00K | 742.00K | 819.00K |
| Gross Profit | -612.00K | -582.00K | -603.00K | -517.00K | -541.00K |
| SG&A Expenses | 9.39M | 8.63M | 8.29M | 8.54M | 10.13M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 20.62M | 19.90M | 19.67M | 19.46M | 21.71M |
| Operating Income | -20.41M | -19.67M | -19.46M | -19.23M | -21.43M |
| Income Before Tax | -21.79M | -21.27M | -19.52M | -20.80M | -21.07M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -21.79 | -21.27 | -19.52 | -20.80 | -21.07 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -21.79M | -21.27M | -19.52M | -20.80M | -21.07M |
| EBIT | -20.41M | -19.67M | -19.46M | -19.23M | -21.43M |
| EBITDA | -20.14M | -19.43M | -19.26M | -19.06M | -21.26M |
| EPS Basic | -1.44 | -1.48 | -1.44 | -1.56 | -1.42 |
| Normalized Basic EPS | -0.67 | -0.69 | -0.66 | -0.72 | -0.71 |
| EPS Diluted | -1.45 | -1.49 | -1.45 | -1.57 | -1.43 |
| Normalized Diluted EPS | -0.67 | -0.69 | -0.66 | -0.72 | -0.71 |
| Average Basic Shares Outstanding | 80.91M | 77.67M | 74.89M | 72.16M | 74.54M |
| Average Diluted Shares Outstanding | 80.91M | 77.67M | 74.89M | 72.16M | 74.54M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -11.17% | -20.06% | -18.75% | -11.77% | -8.70% |